[HTML][HTML] Non-coding RNAs modulating estrogen signaling and response to endocrine therapy in breast cancer

O Treeck, S Haerteis, O Ortmann - Cancers, 2023 - mdpi.com
Simple Summary Endocrine therapy is a common treatment for estrogen-responsive breast
cancer, which is used to block the tumor growth-promoting effect of this hormone. The …

Selective Estrogen Receptor Modulators (SERMs) for the treatment of ER+ breast cancer: An overview

S Das, S Kulkarni, Y Singh, P Kumar… - Journal of Molecular …, 2022 - Elsevier
Breast cancer is a major threat to women's lives throughout the world. Hormone-dependent
or estrogen-receptor positive (ER+) breast cancer accounts for more than 80% of all …

[HTML][HTML] Breast cancer MCF-7 cell spheroid culture for drug discovery and development

G Chen, W Liu, B Yan - Journal of cancer therapy, 2022 - ncbi.nlm.nih.gov
In vitro 3D cancer spheroids (tumoroids) exhibit a drug resistance profile similar to that found
in solid tumors. 3D spheroid culture methods recreate more physiologically relevant …

Rational design, synthesis, antiproliferative activity against MCF-7, MDA-MB-231 cells, estrogen receptors binding affinity, and computational study of …

I Ejaz, MA Javed, MS Jan, M Ikram, A Sadiq… - Bioorganic & Medicinal …, 2022 - Elsevier
Based on the structural architecture of estrogen receptors (ER) agonists/antagonists, we
rationally designed and synthesized indenopyrimidine-2, 5-dione analogs as a starting point …

A comprehensive review on Thiazole based Conjugates as Anti-cancer Agents

R Rana, N Kumar, HK Gulati, A Sharma… - Journal of Molecular …, 2023 - Elsevier
Over the past few decades, a significant number of anticancer drugs have been developed,
both natural and synthetic. Thiazole, a 5-membered distinctive heterocyclic motif with …

Hybridization of molecular docking studies with machine learning based QSAR model for prediction of xanthine oxidase activity

N Kumar, K Kaur, PMS Bedi - Computational and Theoretical Chemistry, 2023 - Elsevier
Xanthine Oxidase inhibitors treat hyperuricemia, but associated side effects have led
researchers to discover new inhibitors with fewer side effects. Our study employed a hybrid …

Sulfonamides as anticancer agents: A brief review on sulfonamide derivatives as inhibitors of various proteins overexpressed in cancer

KA Elsayad, GF Elmasry, ST Mahmoud… - Bioorganic …, 2024 - Elsevier
Sulfonamides have gained prominence as versatile agents in cancer therapy, effectively
targeting a spectrum of cancer-associated enzymes. This review provides an extensive …

Pathology, target discovery, and the evolution of XO inhibitors from the first discovery to recent advances (2020–2023)

N Kumar, K Kaur, N Kaur, E Singh, PMS Bedi - Bioorganic Chemistry, 2023 - Elsevier
Hyperuricemia, a disease characterized by elevation of serum uric acid level beyond 6
mg/dL. This elevation led to appearance of symptoms from joint pain to gout and from gout to …

Synthesis, in silico and investigation of anti-breast cancer activity of new diphenyl urea derivatives: Experimental and computational study

M Gömeç, K Sayin, M Özkaraca, H Özden - Journal of Molecular Structure, 2022 - Elsevier
Cancer is a complex disease that requires multidisciplinary treatment. One of the most
common cancers is breast cancer, and these cancers are usually estrogen receptor-positive …

[HTML][HTML] Cyclopia extracts act as selective estrogen receptor subtype downregulators in estrogen receptor positive breast cancer cell lines: Comparison to standard of …

FR Olayoku, NJD Verhoog, A Louw - Frontiers in Pharmacology, 2023 - frontiersin.org
Breast cancer is the most diagnosed type of cancer amongst women in economically
developing countries and globally. Most breast cancers express estrogen receptor alpha …